Share Price and Basic Stock Data
Last Updated: January 10, 2026, 7:22 am
| PEG Ratio | -4.77 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sree Rayalaseema Hi-Strength Hypo Ltd, operating in the chemicals sector, reported a market capitalization of ₹866 Cr and a share price of ₹504. The company’s revenue from operations stood at ₹1,650 Cr for the fiscal year ending March 2023, reflecting a significant increase from ₹1,267 Cr in the previous year. However, revenue has shown a declining trend recently, with quarterly sales figures decreasing from ₹435 Cr in March 2023 to ₹226 Cr in September 2023. This downward trajectory continued into December 2023, with sales recorded at ₹215 Cr. Despite these fluctuations, the company has maintained a robust presence in the inorganic chemicals market. The operating profit margin (OPM) for the latest quarter was reported at 12%, while the trailing twelve months (TTM) OPM stood at 14%, indicating some resilience amidst revenue challenges. The sales growth over the past few years, peaking in FY 2023, suggests that the company has previously capitalized on market demand effectively.
Profitability and Efficiency Metrics
The profitability metrics of Sree Rayalaseema Hi-Strength Hypo Ltd illustrate a company with stable earnings. The net profit for FY 2023 was reported at ₹154 Cr, a substantial increase from ₹103 Cr in FY 2022. The net profit margin for March 2025 stood at 13.71%, indicating a strong ability to convert revenue into profit compared to typical sector margins. The company posted an interest coverage ratio (ICR) of 66.46x, suggesting excellent capability to meet interest obligations, significantly higher than the industry average. However, operating profit has fluctuated, with a decline in recent quarters, dropping to ₹27 Cr in March 2024 and then to ₹18 Cr in March 2025. The return on equity (ROE) stood at 11%, while the return on capital employed (ROCE) was at 14.9%, reflecting reasonable efficiency in utilizing equity and capital. The cash conversion cycle of 90 days indicates that the company effectively manages its cash flow, although recent increases in inventory days could pose future liquidity risks.
Balance Sheet Strength and Financial Ratios
Sree Rayalaseema Hi-Strength Hypo Ltd’s balance sheet exhibits strong fundamentals, with total reserves reaching ₹993 Cr as of September 2025. The company’s borrowings are minimal, reported at ₹13 Cr, indicating a low leverage position which enhances financial stability. The current ratio stands at 8.99, significantly above the typical threshold of 1, indicating robust liquidity. Furthermore, the price-to-book value (P/BV) ratio is reported at 0.92x, suggesting that the stock is trading at a discount relative to its book value, a potential indicator for value investors. The company reported a total asset value of ₹1,156 Cr alongside a total liability of ₹1,059 Cr, showcasing a solid asset base relative to its obligations. The enterprise value (EV) was recorded at ₹487.59 Cr, and the EV/EBITDA ratio of 3.71 indicates a favorable valuation compared to earnings, reinforcing the investment case for the company.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sree Rayalaseema Hi-Strength Hypo Ltd reflects a strong promoter commitment, with promoters holding 61.84% of the equity as of December 2023. This stability is complemented by a public holding of 38.05%, indicating a healthy distribution of shares among retail investors. However, foreign institutional investors (FIIs) and domestic institutional investors (DIIs) hold minimal stakes, with FIIs at 0.06% and DIIs at 0.05%, which may suggest limited institutional interest. The number of shareholders declined from 64,522 in December 2022 to 43,085 in September 2025, potentially indicating a consolidation of shares among existing investors or a lack of new investor interest. The consistent promoter holding and low institutional stake could signal both confidence from insiders and a need for improved outreach to institutional investors to enhance market perception.
Outlook, Risks, and Final Insight
The outlook for Sree Rayalaseema Hi-Strength Hypo Ltd hinges on its ability to stabilize revenue and manage profitability amid market fluctuations. Key strengths include a strong balance sheet with minimal debt, solid liquidity ratios, and a high interest coverage ratio, positioning the company well for future growth. However, risks include declining revenue trends and potential inventory management challenges, which could impact cash flows. Additionally, limited institutional participation raises questions about broader market confidence. In scenarios where the company can reverse its recent revenue decline and capitalize on operational efficiencies, it may strengthen its market position. Conversely, if sales continue to drop or if operational challenges persist, the company may face pressures on both its profitability and stock performance, warranting close monitoring of quarterly results and strategic initiatives.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Fischer Medical Ventures Ltd | 2,503 Cr. | 38.6 | 125/38.6 | 125 | 5.55 | 0.01 % | 1.08 % | 0.70 % | 1.00 |
| Emmessar Biotech & Nutrition Ltd | 15.0 Cr. | 29.9 | 45.9/25.8 | 65.0 | 16.0 | 0.00 % | 12.6 % | 4.23 % | 10.0 |
| Cochin Minerals & Rutile Ltd | 211 Cr. | 270 | 356/238 | 12.6 | 211 | 2.96 % | 23.3 % | 15.0 % | 10.0 |
| Archean Chemical Industries Ltd | 6,369 Cr. | 516 | 728/408 | 31.1 | 157 | 0.58 % | 16.0 % | 12.0 % | 2.00 |
| Alufluoride Ltd | 336 Cr. | 430 | 503/376 | 16.4 | 144 | 0.70 % | 23.6 % | 20.8 % | 10.0 |
| Industry Average | 4,605.63 Cr | 374.18 | 148.18 | 156.25 | 0.50% | 13.95% | 10.65% | 6.18 |
All Competitor Stocks of Sree Rayalaseema Hi-Strength Hypo Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 344 | 301 | 435 | 261 | 226 | 215 | 165 | 169 | 170 | 138 | 160 | 180 | 182 |
| Expenses | 310 | 274 | 371 | 226 | 199 | 192 | 138 | 142 | 140 | 117 | 143 | 152 | 155 |
| Operating Profit | 34 | 26 | 64 | 35 | 26 | 22 | 27 | 27 | 30 | 21 | 18 | 28 | 27 |
| OPM % | 10% | 9% | 15% | 13% | 12% | 10% | 16% | 16% | 18% | 15% | 11% | 16% | 15% |
| Other Income | 3 | 11 | 20 | 1 | 2 | 4 | 5 | 3 | 9 | 13 | 12 | 6 | 7 |
| Interest | 1 | 0 | 1 | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 1 | 0 | 0 |
| Depreciation | 5 | 5 | 5 | 3 | 3 | 3 | 3 | 1 | 2 | 1 | 1 | 1 | 1 |
| Profit before tax | 31 | 32 | 79 | 33 | 25 | 23 | 27 | 28 | 36 | 32 | 28 | 32 | 32 |
| Tax % | 24% | 26% | 9% | 26% | 27% | 29% | 23% | 26% | 29% | 27% | 19% | 28% | 24% |
| Net Profit | 24 | 24 | 71 | 24 | 18 | 17 | 21 | 20 | 26 | 24 | 23 | 23 | 24 |
| EPS in Rs | 13.79 | 13.72 | 41.45 | 14.17 | 10.78 | 9.69 | 12.22 | 11.94 | 15.12 | 13.71 | 13.23 | 13.64 | 14.20 |
Last Updated: December 29, 2025, 1:33 am
Below is a detailed analysis of the quarterly data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 182.00 Cr.. The value appears strong and on an upward trend. It has increased from 180.00 Cr. (Jun 2025) to 182.00 Cr., marking an increase of 2.00 Cr..
- For Expenses, as of Sep 2025, the value is 155.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 152.00 Cr. (Jun 2025) to 155.00 Cr., marking an increase of 3.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 28.00 Cr. (Jun 2025) to 27.00 Cr., marking a decrease of 1.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Jun 2025) to 15.00%, marking a decrease of 1.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Jun 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 32.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 32.00 Cr..
- For Tax %, as of Sep 2025, the value is 24.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Jun 2025) to 24.00%, marking a decrease of 4.00%.
- For Net Profit, as of Sep 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 23.00 Cr. (Jun 2025) to 24.00 Cr., marking an increase of 1.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 14.20. The value appears strong and on an upward trend. It has increased from 13.64 (Jun 2025) to 14.20, marking an increase of 0.56.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:36 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 295 | 392 | 362 | 366 | 546 | 702 | 689 | 911 | 1,267 | 1,650 | 866 | 638 | 662 |
| Expenses | 262 | 351 | 318 | 317 | 500 | 604 | 587 | 781 | 1,119 | 1,470 | 755 | 542 | 567 |
| Operating Profit | 33 | 41 | 44 | 50 | 46 | 98 | 102 | 130 | 149 | 180 | 111 | 96 | 95 |
| OPM % | 11% | 10% | 12% | 14% | 8% | 14% | 15% | 14% | 12% | 11% | 13% | 15% | 14% |
| Other Income | 9 | 9 | 2 | -2 | 19 | 5 | 4 | 7 | 11 | 34 | 13 | 36 | 38 |
| Interest | 16 | 14 | 11 | 8 | 9 | 16 | 10 | 5 | 3 | 5 | 4 | 2 | 2 |
| Depreciation | 15 | 10 | 10 | 25 | 19 | 45 | 50 | 51 | 19 | 19 | 11 | 6 | 6 |
| Profit before tax | 12 | 26 | 26 | 15 | 37 | 42 | 45 | 81 | 137 | 190 | 109 | 124 | 125 |
| Tax % | 36% | 25% | 27% | -27% | 1% | 52% | 17% | 25% | 25% | 19% | 26% | 25% | |
| Net Profit | 7 | 19 | 19 | 18 | 37 | 20 | 38 | 61 | 103 | 154 | 80 | 93 | 94 |
| EPS in Rs | 5.06 | 13.16 | 12.72 | 11.86 | 22.45 | 11.90 | 22.09 | 35.30 | 59.88 | 89.90 | 46.85 | 53.99 | 54.78 |
| Dividend Payout % | 0% | 11% | 12% | 13% | 9% | 17% | 11% | 8% | 6% | 4% | 6% | 6% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 171.43% | 0.00% | -5.26% | 105.56% | -45.95% | 90.00% | 60.53% | 68.85% | 49.51% | -48.05% | 16.25% |
| Change in YoY Net Profit Growth (%) | 0.00% | -171.43% | -5.26% | 110.82% | -151.50% | 135.95% | -29.47% | 8.33% | -19.34% | -97.57% | 64.30% |
Sree Rayalaseema Hi-Strength Hypo Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -2% |
| 3 Years: | -20% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 20% |
| 3 Years: | -3% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 30% |
| 3 Years: | -7% |
| 1 Year: | 4% |
| Return on Equity | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 16% |
| 3 Years: | 14% |
| Last Year: | 11% |
Last Updated: September 5, 2025, 1:36 pm
Balance Sheet
Last Updated: December 10, 2025, 3:27 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 15 | 15 | 15 | 15 | 16 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 |
| Reserves | 135 | 157 | 173 | 222 | 302 | 308 | 294 | 371 | 553 | 734 | 785 | 905 | 993 |
| Borrowings | 88 | 87 | 85 | 55 | 78 | 52 | 57 | 72 | 28 | 16 | 5 | 15 | 13 |
| Other Liabilities | 130 | 99 | 84 | 60 | 64 | 93 | 76 | 59 | 189 | 174 | 100 | 121 | 133 |
| Total Liabilities | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 | 1,059 | 1,156 |
| Fixed Assets | 200 | 194 | 195 | 182 | 194 | 194 | 161 | 134 | 130 | 105 | 103 | 112 | 111 |
| CWIP | 0 | 5 | 2 | 8 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 32 | 23 | 23 | 43 | 105 | 65 | 18 | 50 | 164 | 268 | 253 | 366 | 407 |
| Other Assets | 135 | 136 | 137 | 118 | 161 | 210 | 262 | 334 | 494 | 568 | 551 | 580 | 638 |
| Total Assets | 367 | 358 | 357 | 352 | 460 | 470 | 445 | 519 | 787 | 941 | 907 | 1,059 | 1,156 |
Below is a detailed analysis of the balance sheet data for Sree Rayalaseema Hi-Strength Hypo Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Reserves, as of Sep 2025, the value is 993.00 Cr.. The value appears strong and on an upward trend. It has increased from 905.00 Cr. (Mar 2025) to 993.00 Cr., marking an increase of 88.00 Cr..
- For Borrowings, as of Sep 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 15.00 Cr. (Mar 2025) to 13.00 Cr., marking a decrease of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 133.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 121.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 12.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,156.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,059.00 Cr. (Mar 2025) to 1,156.00 Cr., marking an increase of 97.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 111.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 111.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 366.00 Cr. (Mar 2025) to 407.00 Cr., marking an increase of 41.00 Cr..
- For Other Assets, as of Sep 2025, the value is 638.00 Cr.. The value appears strong and on an upward trend. It has increased from 580.00 Cr. (Mar 2025) to 638.00 Cr., marking an increase of 58.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,156.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,059.00 Cr. (Mar 2025) to 1,156.00 Cr., marking an increase of 97.00 Cr..
Notably, the Reserves (993.00 Cr.) exceed the Borrowings (13.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -55.00 | -46.00 | -41.00 | -5.00 | -32.00 | 46.00 | 45.00 | 58.00 | 121.00 | 164.00 | 106.00 | 81.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 33 | 54 | 30 | 38 | 46 | 43 | 39 | 38 | 33 | 45 | 59 |
| Inventory Days | 67 | 42 | 37 | 55 | 34 | 34 | 36 | 27 | 62 | 39 | 24 | 49 |
| Days Payable | 97 | 79 | 39 | 66 | 21 | 38 | 24 | 8 | 33 | 22 | 10 | 18 |
| Cash Conversion Cycle | 3 | -4 | 51 | 19 | 51 | 41 | 55 | 57 | 67 | 50 | 59 | 90 |
| Working Capital Days | -23 | -15 | 1 | 12 | 16 | 32 | 24 | 23 | 47 | 45 | 67 | 79 |
| ROCE % | 11% | 13% | 14% | 9% | 9% | 14% | 15% | 21% | 26% | 26% | 16% | 15% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 52.47 | 46.01 | 89.97 | 59.88 | 35.29 |
| Diluted EPS (Rs.) | 52.47 | 46.01 | 89.97 | 59.88 | 35.29 |
| Cash EPS (Rs.) | 55.22 | 52.18 | 101.14 | 71.08 | 64.77 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 534.98 | 466.47 | 437.58 | 332.26 | 226.03 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 534.98 | 466.47 | 437.58 | 332.26 | 226.03 |
| Revenue From Operations / Share (Rs.) | 371.59 | 504.53 | 961.34 | 738.30 | 530.63 |
| PBDIT / Share (Rs.) | 76.62 | 77.32 | 124.97 | 92.87 | 79.77 |
| PBIT / Share (Rs.) | 72.35 | 71.14 | 113.70 | 81.67 | 50.29 |
| PBT / Share (Rs.) | 69.42 | 62.50 | 110.93 | 79.80 | 47.10 |
| Net Profit / Share (Rs.) | 50.96 | 46.01 | 89.87 | 59.88 | 35.29 |
| NP After MI And SOA / Share (Rs.) | 52.47 | 46.01 | 89.87 | 59.88 | 35.29 |
| PBDIT Margin (%) | 20.61 | 15.32 | 12.99 | 12.57 | 15.03 |
| PBIT Margin (%) | 19.47 | 14.10 | 11.82 | 11.06 | 9.47 |
| PBT Margin (%) | 18.68 | 12.38 | 11.53 | 10.80 | 8.87 |
| Net Profit Margin (%) | 13.71 | 9.11 | 9.34 | 8.11 | 6.65 |
| NP After MI And SOA Margin (%) | 14.12 | 9.11 | 9.34 | 8.11 | 6.65 |
| Return on Networth / Equity (%) | 9.80 | 9.86 | 20.54 | 18.02 | 15.61 |
| Return on Capital Employeed (%) | 12.35 | 14.20 | 25.52 | 24.05 | 21.55 |
| Return On Assets (%) | 8.42 | 8.64 | 17.18 | 13.04 | 11.67 |
| Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.01 | 0.03 | 0.15 |
| Asset Turnover Ratio (%) | 0.64 | 0.95 | 1.96 | 1.94 | 1.89 |
| Current Ratio (X) | 8.99 | 9.75 | 4.17 | 2.35 | 2.65 |
| Quick Ratio (X) | 8.38 | 9.17 | 3.22 | 1.65 | 2.32 |
| Inventory Turnover Ratio (X) | 17.86 | 5.03 | 4.24 | 5.39 | 9.03 |
| Dividend Payout Ratio (NP) (%) | 5.71 | 8.69 | 3.89 | 5.01 | 7.08 |
| Dividend Payout Ratio (CP) (%) | 5.28 | 7.66 | 3.46 | 4.22 | 3.86 |
| Earning Retention Ratio (%) | 94.29 | 91.31 | 96.11 | 94.99 | 92.92 |
| Cash Earning Retention Ratio (%) | 94.72 | 92.34 | 96.54 | 95.78 | 96.14 |
| Interest Coverage Ratio (X) | 66.46 | 33.31 | 45.16 | 49.69 | 25.01 |
| Interest Coverage Ratio (Post Tax) (X) | 46.75 | 23.54 | 33.48 | 33.04 | 12.06 |
| Enterprise Value (Cr.) | 487.59 | 518.25 | 489.04 | 718.64 | 328.19 |
| EV / Net Operating Revenue (X) | 0.76 | 0.59 | 0.29 | 0.56 | 0.36 |
| EV / EBITDA (X) | 3.71 | 3.90 | 2.28 | 4.51 | 2.40 |
| MarketCap / Net Operating Revenue (X) | 1.33 | 0.97 | 0.42 | 0.64 | 0.44 |
| Retention Ratios (%) | 94.28 | 91.30 | 96.10 | 94.98 | 92.91 |
| Price / BV (X) | 0.92 | 1.05 | 0.94 | 1.43 | 1.05 |
| Price / Net Operating Revenue (X) | 1.33 | 0.97 | 0.42 | 0.64 | 0.44 |
| EarningsYield | 0.10 | 0.09 | 0.21 | 0.12 | 0.14 |
After reviewing the key financial ratios for Sree Rayalaseema Hi-Strength Hypo Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For Diluted EPS (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For Cash EPS (Rs.), as of Mar 25, the value is 55.22. This value is within the healthy range. It has increased from 52.18 (Mar 24) to 55.22, marking an increase of 3.04.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 534.98. It has increased from 466.47 (Mar 24) to 534.98, marking an increase of 68.51.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 534.98. It has increased from 466.47 (Mar 24) to 534.98, marking an increase of 68.51.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 371.59. It has decreased from 504.53 (Mar 24) to 371.59, marking a decrease of 132.94.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 76.62. This value is within the healthy range. It has decreased from 77.32 (Mar 24) to 76.62, marking a decrease of 0.70.
- For PBIT / Share (Rs.), as of Mar 25, the value is 72.35. This value is within the healthy range. It has increased from 71.14 (Mar 24) to 72.35, marking an increase of 1.21.
- For PBT / Share (Rs.), as of Mar 25, the value is 69.42. This value is within the healthy range. It has increased from 62.50 (Mar 24) to 69.42, marking an increase of 6.92.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 50.96. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 50.96, marking an increase of 4.95.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 52.47. This value is within the healthy range. It has increased from 46.01 (Mar 24) to 52.47, marking an increase of 6.46.
- For PBDIT Margin (%), as of Mar 25, the value is 20.61. This value is within the healthy range. It has increased from 15.32 (Mar 24) to 20.61, marking an increase of 5.29.
- For PBIT Margin (%), as of Mar 25, the value is 19.47. This value is within the healthy range. It has increased from 14.10 (Mar 24) to 19.47, marking an increase of 5.37.
- For PBT Margin (%), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 12.38 (Mar 24) to 18.68, marking an increase of 6.30.
- For Net Profit Margin (%), as of Mar 25, the value is 13.71. This value exceeds the healthy maximum of 10. It has increased from 9.11 (Mar 24) to 13.71, marking an increase of 4.60.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.12. This value is within the healthy range. It has increased from 9.11 (Mar 24) to 14.12, marking an increase of 5.01.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.80. This value is below the healthy minimum of 15. It has decreased from 9.86 (Mar 24) to 9.80, marking a decrease of 0.06.
- For Return on Capital Employeed (%), as of Mar 25, the value is 12.35. This value is within the healthy range. It has decreased from 14.20 (Mar 24) to 12.35, marking a decrease of 1.85.
- For Return On Assets (%), as of Mar 25, the value is 8.42. This value is within the healthy range. It has decreased from 8.64 (Mar 24) to 8.42, marking a decrease of 0.22.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.95 (Mar 24) to 0.64, marking a decrease of 0.31.
- For Current Ratio (X), as of Mar 25, the value is 8.99. This value exceeds the healthy maximum of 3. It has decreased from 9.75 (Mar 24) to 8.99, marking a decrease of 0.76.
- For Quick Ratio (X), as of Mar 25, the value is 8.38. This value exceeds the healthy maximum of 2. It has decreased from 9.17 (Mar 24) to 8.38, marking a decrease of 0.79.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 17.86. This value exceeds the healthy maximum of 8. It has increased from 5.03 (Mar 24) to 17.86, marking an increase of 12.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 5.71. This value is below the healthy minimum of 20. It has decreased from 8.69 (Mar 24) to 5.71, marking a decrease of 2.98.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 5.28. This value is below the healthy minimum of 20. It has decreased from 7.66 (Mar 24) to 5.28, marking a decrease of 2.38.
- For Earning Retention Ratio (%), as of Mar 25, the value is 94.29. This value exceeds the healthy maximum of 70. It has increased from 91.31 (Mar 24) to 94.29, marking an increase of 2.98.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 94.72. This value exceeds the healthy maximum of 70. It has increased from 92.34 (Mar 24) to 94.72, marking an increase of 2.38.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 66.46. This value is within the healthy range. It has increased from 33.31 (Mar 24) to 66.46, marking an increase of 33.15.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 46.75. This value is within the healthy range. It has increased from 23.54 (Mar 24) to 46.75, marking an increase of 23.21.
- For Enterprise Value (Cr.), as of Mar 25, the value is 487.59. It has decreased from 518.25 (Mar 24) to 487.59, marking a decrease of 30.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.76. This value is below the healthy minimum of 1. It has increased from 0.59 (Mar 24) to 0.76, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 25, the value is 3.71. This value is below the healthy minimum of 5. It has decreased from 3.90 (Mar 24) to 3.71, marking a decrease of 0.19.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
- For Retention Ratios (%), as of Mar 25, the value is 94.28. This value exceeds the healthy maximum of 70. It has increased from 91.30 (Mar 24) to 94.28, marking an increase of 2.98.
- For Price / BV (X), as of Mar 25, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.05 (Mar 24) to 0.92, marking a decrease of 0.13.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.33. This value is within the healthy range. It has increased from 0.97 (Mar 24) to 1.33, marking an increase of 0.36.
- For EarningsYield, as of Mar 25, the value is 0.10. This value is below the healthy minimum of 5. It has increased from 0.09 (Mar 24) to 0.10, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sree Rayalaseema Hi-Strength Hypo Ltd:
- Net Profit Margin: 13.71%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 12.35% (Industry Average ROCE: 13.95%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.8% (Industry Average ROE: 10.65%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 46.75
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 8.38
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.41 (Industry average Stock P/E: 148.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.71%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Inorganic - Others | Gondiparla, Kurnool Andhra Pradesh 518004 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. T G Shilpa Bharath | Chairperson & Managing Director |
| Mr. H Gurunath Reddy | Non Executive Director |
| Mr. Satyam Gadwal | Non Executive Director |
| Mr. A Kailashnath | Independent Director |
| Mr. Kamma Edlapalli Krishna | Independent Director |
| Mrs. R Triveni | Independent Woman Director |
FAQ
What is the intrinsic value of Sree Rayalaseema Hi-Strength Hypo Ltd?
Sree Rayalaseema Hi-Strength Hypo Ltd's intrinsic value (as of 12 January 2026) is ₹437.82 which is 10.65% lower the current market price of ₹490.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹841 Cr. market cap, FY2025-2026 high/low of ₹726/464, reserves of ₹993 Cr, and liabilities of ₹1,156 Cr.
What is the Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Market Cap of Sree Rayalaseema Hi-Strength Hypo Ltd is 841 Cr..
What is the current Stock Price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 12 January 2026?
The current stock price of Sree Rayalaseema Hi-Strength Hypo Ltd as on 12 January 2026 is ₹490.
What is the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sree Rayalaseema Hi-Strength Hypo Ltd stocks is ₹726/464.
What is the Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Stock P/E of Sree Rayalaseema Hi-Strength Hypo Ltd is 8.41.
What is the Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Book Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 588.
What is the Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Dividend Yield of Sree Rayalaseema Hi-Strength Hypo Ltd is 0.61 %.
What is the ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd?
The ROCE of Sree Rayalaseema Hi-Strength Hypo Ltd is 14.9 %.
What is the ROE of Sree Rayalaseema Hi-Strength Hypo Ltd?
The ROE of Sree Rayalaseema Hi-Strength Hypo Ltd is 11.0 %.
What is the Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd?
The Face Value of Sree Rayalaseema Hi-Strength Hypo Ltd is 10.0.